ALLURION TECHNOLOGIES, INC.

Offers a swallowable gastric balloon & digital platform for non-surgical weight loss.

ALUR | NYSE

Overview

Corporate Details

ISIN(s):: US02008G1022
LEI:
Country:: United States of America
Address:: 11 HURON DR STE 200, 1760 NATICK
Website:: https://www.allurion.com/en
Sector:: Manufacturing
Industry:: Manufacture of medical and dental instruments and supplies

Description

Allurion Technologies, Inc. is a medical technology company dedicated to ending obesity. The company develops and markets the Allurion Program, a comprehensive weight-loss platform centered around the world's first and only swallowable, procedure-less gastric balloon. The program integrates the medical device with a full digital ecosystem, including the Allurion App, a Connected Scale, and an AI-powered coach, to provide real-time tracking and support. This is combined with professional nutritional coaching and medical supervision over a minimum six-month period. The platform is designed to help patients achieve and maintain metabolically healthy weight loss without surgery or endoscopy, and is available through a global network of partner clinics.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all ALLURION TECHNOLOGIES, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ALLURION TECHNOLOGIES, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for ALLURION TECHNOLOGIES, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
PULSE BIOSCIENCES, INC. Developing nsPFA bioelectric tech for precise, non-thermal tissue ablation in cardiology.	United States of America	PLSE
Qiagen N.V. Provides 'Sample to Insight' solutions for molecular analysis in research and clinical healthcare.	Netherlands	QIA
QIAGEN N.V. Develops sample-to-insight tech for molecular diagnostics, research, and pharma applications.	United States of America	QGEN
QLife Holding AB Develops an at-home IVD platform for biomarker and virus testing from blood samples.	Sweden	QLIFE
QuantaMatrix Incorporated IVD specialist in rapid antimicrobial susceptibility testing for critical infections like sepsis.	South Korea	317690
Quanterix Corp Offers an ultra-sensitive immunoassay platform for biomarker analysis in research and diagnostics.	United States of America	QTRX
Raphas Co., Ltd. Develops dissolving microneedle patches for cosmetic, medical, and pharmaceutical applications.	South Korea	214260
Redsense Medical AB Develops FDA/CE-marked blood loss alarms for hemodialysis using fiber optic tech for EU/US markets.	Sweden	REDS
RenovoRx, Inc. Develops a device platform for delivering targeted therapies directly to solid tumors.	United States of America	RNXT
RESMED INC Develops cloud-connected medical devices and software for sleep apnea and respiratory care.	United States of America	RMD